Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Actuarial


ATBPF

RE:RE:RE:ATE Longs: Read posts carefully!

I am an actuary so I know exactly this trial is flawed and it is meaningless...

March 24, 2018

ATBPF

RE:ATE Longs: Read posts carefully!

https://www.forbes.com/sites/matthewherper/2016/11/13/controversial-study-of...

March 24, 2018

ATBPF

RE:RE:But today, Dr. Steven Nissen, chairman of the department of

"At the end of the day, NSAIDs are not great for us. There are side...

March 24, 2018

ATBPF

RE:But today, Dr. Steven Nissen, chairman of the department of

The authors pointed out two weaknesses in their work. First, the study lacked...

March 24, 2018

PMN

RE:RE:Wall down

someone short PMN at $.51 with hugh position (worth $6.6M) a few weeks ago...

March 6, 2018

PMN

Someone need to cover this huge short position eventually

Historical Short Volume Data for PMN.TO 2018 | 2017 | 2016 | 2015 Date Feb 1...

March 1, 2018

PMN

RE:RE:RE:RE:RE:RE:Non Believers

goldtech wrote: This company ...... either cannot deliver or is inept in...

November 9, 2017

PMN

RE:FDA may fast track treatment after review

CT1812 Adverse events were mild to moderate in severity and mainly included...

October 19, 2017

PMN

RE:RE:RE:FDA may fast track treatment after review

I am not an expert in the area ...... A few comments on CT1812. CT1812...

October 19, 2017

PMN

RE:History of Axovant ...

Again, Roivant/Axovant is nothing but a scam. Who is getting rich in this...

October 2, 2017

PMN

RE:Pmn mentioned in this article today

Axovant is just a joke - it is a family controlled company not much better...

September 26, 2017

PMN

RE:RE:News out - Something cooking

The maximum value of a warrant is $0.25 (i.e., warrant holders would have an...

August 2, 2017

COTQF

RE:COTI 219

It took Kevetrin three years to complete phase 1 (August 2, 2012 - Feb 23...

July 28, 2017

PMN

RE:Artcile in Nature News

Nice post! Two key points I get from the article: amyloid- might lead/cause...

July 14, 2017

COTQF

RE:heads out of our asses

Silva at least have a choice not to spend the $120,000 on PR for nothing .......

June 23, 2017

PMN

RE:RE:Lots of interest in tdp43 and tau work being done at PMN

Thanks RC! Seems the only missing piece in the portfolio being Tau ......

June 21, 2017

PMN

RE:DR Cashman presents at ALS Meeting

This was last year ......

June 19, 2017

PMN

RE:Analysis of PET Scans Suggests Link Between Amyloid and Tau

Only 88 sample data points, and also need to split the data into modeling...

June 12, 2017

PMN

German Biotech - toxic culprit is really the early oligomer

http://labiotech.eu/probiodrug-alzheimers-pq912-phase-iia/

June 12, 2017

V.AQS

RE:RE:RE:Milestone Update

Great post chipmuki1234567!

June 12, 2017

Featured Company